Efficacy and safety of rh‐endostatin (Endostar) combined with pemetrexed/cisplatin followed by rh‐endostatin plus pemetrexed maintenance in non‐small cell lung cancer: A retrospective comparison with standard chemotherapy

BACKGROUND: Recombinant human endostatin (rh‐endostatin) plus standard chemotherapy in advanced non‐small cell lung cancer (NSCLC) patients has shown improved efficacy; however, it is unclear whether it is effective and safe when added to pemetrexed/cisplatin and used as maintenance therapy. METHODS...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Thorac Cancer
Hoofdauteurs: Zhou, Shengyu, Zuo, Lijie, He, Xiaohui, Pi, Jinping, Jin, Jun, Shi, Yuankai
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley & Sons Australia, Ltd 2018
Onderwerpen:
Original Articles
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6209785/
https://ncbi.nlm.nih.gov/pubmed/30152052
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12827
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items